Export

You can select particular sections to be included in the output file.

Model List of Essential Medicines

clear Found 5 recommendations for 5 medicines and 0 therapeutic equivalents
Removed recommendations and rejected applications are shown. Hide them.
6.4.4.2.2. Medicines for hepatitis C > Non-pangenotypic direct-acting antiviral combinations
  1. Dasabuvir General information
    Section
    Medicines for hepatitis C > Non-pangenotypic direct-acting antiviral combinations
    • Oral > Solid: 250 mg tablet
  2. Elbasvir + grazoprevir General information
    Section
    Medicines for hepatitis C > Non-pangenotypic direct-acting antiviral combinations
    • Oral > Solid: 50 mg + 100 mg
  3. Ledipasvir + sofosbuvir General information
    Section
    Medicines for hepatitis C > Non-pangenotypic direct-acting antiviral combinations
    • Oral > Solid: 90 mg + 400 mg tablet
  4. Ombitasvir + paritaprevir + ritonavir General information
    Section
    Medicines for hepatitis C > Non-pangenotypic direct-acting antiviral combinations
    • Oral > Solid: 12.5 mg + 75 mg + 50 mg tablet
  5. Simeprevir General information
    Section
    Medicines for hepatitis C > Non-pangenotypic direct-acting antiviral combinations
    • Oral > Solid: 150 mg